UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - gang+zeng
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
2017-773 Optimizing B Cell Epitope-Based Autoantibody Detection in Cancer Patients
Optimizing B Cell Epitope-Based Autoantibody Detection In Cancer PatientsSUMMARYUCLA researchers from the Department of Urology have invented a new approach to optimize detection of autoantibody response using Luminex microbead-based multiplex assay. This approach bypasses the difficult process of purifying whole proteins by using select combinations...
Published: 7/19/2023
|
Inventor(s):
Gang Zeng
Keywords(s):
Diagnostic Markers & Platforms
,
Diagnostic Platform Technologies (E.G. Microfluidics)
,
Immunotherapy
,
Life Science Research Tools
,
Nucleic Acid Platform Systems
,
Targets And Assays
,
Therapeutics & Vaccines
Category(s):
Life Science Research Tools
,
Diagnostic Markers
,
Diagnostic Markers > Targets And Assays
,
Platforms > Diagnostic Platform Technologies
,
Platforms > Drug Delivery > Nucleic Acid Platform Systems
,
Therapeutics
,
Therapeutics > Immunology And Immunotherapy
Peptide Epitopes as Biomarkers for Prostate Cancer
Case 2009-047UCLA researchers have discovered several peptide epitopes that are potentially useful biomarkers for prostate cancer. Tests utilizing these peptides may provide more specific prostate cancer diagnosis, improved observation of progression of the disease and response to treatments.BACKGROUNDProstate cancer is the most common cancer in men...
Published: 7/19/2023
|
Inventor(s):
Gang Zeng
Keywords(s):
Antibodies
,
Diagnostic Markers & Platforms
,
Life Science Research Tools
,
Oncology
Category(s):
Life Science Research Tools
,
Life Science Research Tools > Antibodies
,
Diagnostic Markers
,
Therapeutics > Oncology
Epitopes for Detection of Antibodies Against Tumor Antigens
Case 2004-496UCLA researchers have developed a new product for the detection, prognosis and prediction of multiple cancers based on the simultaneous detection of serum antibodies to multiple tumor-associated antigens. The method bypasses the expensive and difficult requirement for purification of individual recombinant TAA proteins by using chemically...
Published: 7/19/2023
|
Inventor(s):
Gang Zeng
Keywords(s):
Immunology
,
Immunotherapy
,
Oncology
,
Oncology (Small Molecules, Peptides and Antibodies)
,
Oncology Immunotherapy
,
Therapeutics & Vaccines
Category(s):
Diagnostic Markers > Immunology
,
Therapeutics
,
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Oncology > Oncology Immunotherapy
,
Therapeutics > Oncology > Oncology (Small Molecules)